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Abstract
Background: Many breastfeeding women seek medical care from general practitioners (GPs) for various health 
problems and GPs may consider prescribing medicines in these consultations. Prescribing medicines to a 
breastfeeding mother may lead to untimely cessation of breastfeeding or a breastfeeding mother may be denied 
medicines due to the possible risk to her infant, both of which may lead to unwanted consequences. Information on 
factors governing GPs' decision-making and their views in such situations is limited.
Methods: GPs providing shared maternity care at the Royal Women's Hospital, Melbourne were surveyed using an 
anonymous postal survey to determine their knowledge, attitudes and practices on medicines and breastfeeding, in 
2007/2008 (n = 640). Content analysis of their response to a question concerning decision-making about the use of 
medicine for a breastfeeding woman was conducted. A thematic network was constructed with basic, organising and 
global themes.
Results: 335 (52%) GPs responded to the survey, and 253 (76%) provided information on the last time they had to 
decide about the use of medicine for a breastfeeding woman. Conditions reported were mastitis (24%), other 
infections (24%) and depressive disorders (21%). The global theme that emerged was "complexity of managing risk in 
prescribing for breastfeeding women". The organising themes were: certainty around decision-making; uncertainty around 
decision-making; need for drug information to be available, consistent and reliable; joint decision-making; the vulnerable 
"third party" and infant feeding decision. Decision-making is a spectrum from a straight forward decision, such as 
treatment of mastitis, to a complicated one requiring multiple inputs and consideration. GPs use more information 
seeking and collaboration in decision-making when they perceive the problem to be more complex, for example, in 
postnatal depression.
Conclusion: GPs feel that prescribing medicines for breastfeeding women is a contentious issue. They manage the risk 
of prescribing by gathering information and assessing the possible effects on the breastfed infant. Without evidence-
based information, they sometimes recommend cessation of breastfeeding unnecessarily.
Background
Both WHO and UNICEF recommend exclusive breastfeed-
ing for six months and continuing breastfeeding together
with appropriate complementary feeding for two years or
beyond [1]. During the postpartum period and thereafter,
lactating women may face numerous health issues needing
medicines [2,3]. In a study conducted in Brazil 96% of
women received medicines in the immediate postpartum
period [4]. A study among postpartum mothers in Victoria,
Australia, found that 17% of women reported feeling
depressed or very unhappy for more than few weeks, 42%
of having backache and 14% mastitis [5]. Lactating women
may also experience incidental problems like headache and
musculoskeletal pain, upper respiratory tract infections
(URTI), urinary tract infections (UTI) and dental problems.
Proper management of such conditions is crucial for suc-
cessful breastfeeding and well-being of the mother.
However, whether GPs are equipped with the proper
knowledge and skills in managing such situations is a
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poorly researched area. In a study among GPs in Victoria,
approximately 75% claimed they were confident in dealing
with mastitis in the postnatal period as opposed to 39% with
neck pain and 26% with postnatal depression [6]. It has
been found that physicians advise against breastfeeding
when prescribing certain drugs, despite established safety
during breastfeeding [7].
Prescribing medicines to a breastfeeding mother may lead
to untimely cessation of breastfeeding or a breastfeeding
mother may be denied medicines due to the possible risk to
her infant [2,8]. Both of these situations may lead to poorer
outcomes for mother and/or child.
In this paper, we explore GPs' decision-making in situa-
tions where they are considering recommending or pre-
scribing a medicine for a breastfeeding woman.
Methods
An anonymous postal survey was conducted with general
practitioners (GPs) providing shared maternity care at the
Royal Women's Hospital (RWH), Melbourne, Australia, to
assess their knowledge, attitudes and practices on medi-
cines and breastfeeding (see Amir & Pirotta for more infor-
mation [9]). The survey was based on items from
Brodribb's questionnaire [10], the current literature and four
in-depth interviews with GPs conducted by LA. A current
list of GPs was obtained from the RWH (n = 666). The
questionnaires consisting of closed and open ended ques-
tions and were mailed out in November 2007 and February
2008 with a cover letter and reply-paid envelope. A
reminder post card was sent two weeks after the November
mail out.
Relevant to this article are the last two items in the ques-
tionnaire which were open ended questions. We designed a
structured question asking the participant about their last
experience of using a medicine for a breastfeeding woman
to elicit a free-text response with depth and robustness [11]:
"Thinking about the last time you had to make a decision
about use of a medicine (prescription, over-the-counter or
complementary) for a breastfeeding woman, please
describe - what was the situation? what did you decide?
your reasons for the decision, and how did you feel about
the decision-making process?" We asked GPs to report "the
last time" they had to make a decision, so we could avoid
GPs reporting their most difficult prescribing scenarios,
reduce recall bias and also gather some information on the
relative frequency of conditions requiring medicines in the
postpartum. The final item was a request for further com-
ments (identified as "Comment" in Results).
We undertook content analyses of these two items [12].
The medical conditions were tabulated and summarised; the
number of words in GPs' responses were counted (median
and range are reported). Inductive content analysis, in
which themes and constructs were derived from the data
without imposing a prior framework was conducted [12]. A
thematic network was used in analysing GPs' responses by
deriving basic themes emerging from the codes given to
their words, phrases or sentences [13]. These basic themes
were organised into clusters of similar issues, called the
organising themes. These organising themes gave rise to an
overall global theme, which summarises and makes sense
of the clusters of lower-order themes [13].
In reporting our results, GPs' responses are identified by a
study identification number after each quotation. An ellip-
sis (...) is used when words have been deleted. Ethical
approval was obtained from the Human Research Ethics
Committees at La Trobe University and the University of
Melbourne, and the Human Research and Ethics Commit-
tees of the RWH. Completion of the anonymous survey was
taken as informed consent to participate.
Results
Three hundred and thirty five GPs responded, giving a
response rate of 52% (335/640; 26 potential participants
were ineligible). Approximately 76% (253/335) of respon-
dents described the last occasion of decision-making
regarding use of medicines in a breastfeeding woman. The
median (range) of words used in this item was 19 (2-116).
Over one third (37%, 125/335) responded to "any com-
ments about medicine and breastfeeding". To summarise
the demographic and personal characteristics of the respon-
dents: 70% of GPs were female; about 37% were in the age
bracket of 45 to 54 years; most had obtained their medical
degree in Australia (84%); 90% had children; and 49% of
GPs or their partners had over 12 months of breastfeeding
experience.
Table 1 presents the health issues of breastfeeding women
who presented for treatment. The commonest groups of
conditions were infections in general (50%, 126/253), of
which half were mastitis (24%, 60/253), and depressive dis-
orders (21%, 54/253).
Most GPs who cited an infection, especially mastitis,
reported the information in a brief, precise manner (median
= 12 words, range = 2-46) whereas those who mentioned a
depressive disorder tended to write a lengthy explanation
(median = 28 words, range = 3-90). Examples of mastitis
responses:
•  "Mastitis. Treated with Fluclox [flucloxacillin]. Easy
decision on clinical grounds." (ID 8) (9 words)
In comparison, the description of depressive disorders
was wordier and less confident:
• "Breastfeeding mother with postnatal depression. Dis-
cussion took place regarding safety of medication in combi-
nation with breastfeeding. Decision was made to try
Lexapro [escitalopram] 5 mg daily initially with careful
monitoring of the baby and maternal symptoms. No adverse
effects were detected. Mother is currently on Lexapro 10
mg, improvement in symptoms with no adverse effects on
the baby noted - baby is thriving." (ID 158) (62 words)Jayawickrama et al. BMC Research Notes 2010, 3:82
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Emerging themes
Analysis of the 253 responses revealed six organising
themes that emerged from the responses: certainty around
decision making; uncertainty around decision-making;
need for drug information to be available, consistent and
reliable; joint decision-making, the vulnerable "third
party"; and infant feeding decision. There was one global
theme identified: complexity in managing risk in prescrib-
ing for breastfeeding women (see Table 2).
Certainty and uncertainty around the decision-making 
process
The first two organising themes which emerged from the
comments GPs made with regard to their decision-making
process related to their emotional response. GPs either
reported positive feelings which were mainly associated
with a certainty about the decision or negative feelings
when they were less certain.
Positive feelings on decision-making process
The basic themes used to describe positive feelings were
comfortable, confident, routine and happy. Of the 60 GPs
Table 1: Health issues in breastfeeding women reported by GPs (n = 253)
Condition Individual health issue Categories of health issues
n% n %
Infections 126 49.8
Mastitis 60 23.7
Other infections (66) (26.1)
Endometritis 11 4.3
Tonsillitis 9 3.6
RTI 8 3.2
UTI 7 2.8
Nipple thrush 6 2.4
"Antibiotics" 6 2.4
Common cold 3 1.2
Other gynaecological 
infection*
31 . 2
Sinusitis 2 0.8
Giardia 2 0.8
Miscellaneous infections 9 3.6
Depressive disorders 54 21.3
Use of analgesics 13 5.1
Contraception 93 . 6
Low milk supply 83 . 2
Atopy 83 . 2
Hay fever 3 1.2
Asthma 2 0.8
Antihistamines 2 0.8
Urticaria 1 0.4
Other conditions** 23 9.1
General comments (no specific 
situation)
10 4.0
*v. discharge/vaginitis/pelvic infection
**gastritis/reflux, anaemia, epilepsy, anal fissure, drugs, breast engorgementJayawickrama et al. BMC Research Notes 2010, 3:82
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who reported treating mastitis, 48 (80%) were comfortable
with their decision: "... Mastitis unlikely to resolve without
Ab [antibiotic]. Very comfortable." (ID 300)
GPs were also confident about treating other infections:
"Antibiotic - needed to be suitable for breastfeeding other-
wise no concern. Advised re baby effects of no signifi-
cance." (ID 131)
Negative feelings on decision-making process
GPs reported negative feelings such as difficult, concern
and doubt. These feelings were more evident with prescrib-
ing antidepressants than with antibiotics; of the 23 negative
feelings, only one related to mastitis, while eight related to
depression/anxiety: "... Concerns about SSRI during breast-
feeding by both me and patient. Decision-making process is
always fraught and made difficult by conflicting informa-
tion." (ID 115) and "... I think the risks of depression (post-
partum) often outweigh the risks of the antidepressants. I
felt that there are no right answers to the problem." (ID 24)
Need for drug information to be available, consistent and 
reliable
Before prescribing for a breastfeeding woman, many GPs
needed to check sources for information on safety of the
medicine; this was not straight forward as sources gave
conflicting responses, and sometimes pharmacists' opinion
on medicines in breastfeeding was at odds with their own
decision.
Accessing available drug information
The need to verify the suitability of the drug to be used in
breastfeeding women arose in many situations. Sources of
information ranged from Therapeutic Guidelines [14],
MIMS (a commercial medicines inventory) [15], RWH
Table 2: Basic, organising and global themes
Basic themes Organising themes Global theme
Comfortable Certainty around decision-making
Confident
Routine
Happy
Difficult Uncertainty around decision-making
Concerned
Doubt
Accessing available drug information Need for drug information to be available, 
consistent and reliable
Problems with available drug information
Time-consuming
Issues with pharmacists Complexity of managing risk in 
prescribing for breastfeeding women
Involving other health professionals in 
decision-making process
Joint decision-making
Involving mother in decision-making 
process
Risk The vulnerable "third party"
Safety
Exposure to infant
To continue breastfeeding Infant feeding decision
To give infant formulaJayawickrama et al. BMC Research Notes 2010, 3:82
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drug advisory line, pharmacists, specialists (psychiatrists,
microbiologist), to Product Information. GPs accessed this
information using printed books, online sources, telephone
consultations, as well as medical journals and magazines.
"Depression ... Consulted RWH book, psychiatrist, dis-
cussion with pt. [patient] re risk etc." (ID 199)
"Considering antibiotics for skin infection. I check prod-
uct information (PI) on computer to determine safety status
of the medication for breastfeeding. I try always to confirm
safety on the PI first." (ID 331)
"Hay fever. Rhinocort [budesonide]. Avoid antihista-
mines. Time consuming. Used 2 books + Medical Director
[software program] information. Different recommenda-
tions re: safety of antihistamines." (ID 144)
GPs mentioned seeking drug information from pharma-
cists at several maternity hospitals in Melbourne. These
professionals were highly regarded ("The pharmacist at
RWH excellent - gives various sources of information and
good opinion re: overall management. If not in, she always
rings you back - very reliable." ID 301 Comment).
In the comments section, a number of respondents
requested easy access - preferably online - to evidence-
based information on the use of medicines for breastfeeding
women:
"I would appreciate ready access to detailed information
- books often get misplaced, so internet access would be
great." (ID 60 Comment) and "... We need a dedicated reli-
able easy access source." (ID 164 Comment)
Problems with available drug information
Non-availability of easily accessible, evidence based, up to
date information on medicines in breastfeeding was men-
tioned. GPs often mentioned that their sources of informa-
tion were conflicting and often "over cautious".
"Depression. Most information is 'personal decision' i.e.
no good evidence. Reasons for decision - local psychiatrist
opinion, RWH pharmacist's opinion. Difficult finding up to
date info." (ID 152)
"SSRI in a breastfeeding woman. That it was acceptable.
I had to look back at past Australian Doctor [magazine]
articles b/c [because] the online sources of MIMS info was
too overcautious. OK once I had read the article. I feel able
to make an informed decision." (ID 161)
The process of seeking information was mentioned as
time-consuming by three GPs:
"Depression. Efexor [venlafaxine]. Checked with Box
Hill Hospital pharmacist via phone. Got the most reliable
and up to date info but the information took hours to obtain.
ie. too long." (ID 321)
Some GPs mentioned wanting more information or that
they would have liked guidelines:
"Antibiotics for mastitis. Decided to use antibiotics +
continue breastfeeding/expressing. Mum needed medica-
tion. I still lacked clear guidelines as to possible effects on
baby + what could have been better option." (ID 283)
"A guide similar to preg[nancy] category guide A, B
1,2,3, etc would be useful" (ID 93 Comment)
Although the questionnaire did not directly address the
drug categories for pregnancy, it was evident that there is
confusion among some GPs about the appropriate use of
these categories. Some GPs incorrectly believed that preg-
nancy categories could be used to assess safety in breast-
feeding:
"... In general I try to search for a medication that is cate-
gory A (for pregnancy) & considered safe for breastfeed-
ing". (ID 117 Comment)
"It is easier to get info on pregnancy & medication than it
is to get info[rmation] on breastfeeding & medication. If in
doubt, I tend to check the pregnancy category. If it is safe in
pregnancy, I assume it is safe in breastfeeding...." (ID 76
Comment)
Several GPs mentioned the need for safety information
for complementary medicines: "We need more access to
info[rmation] relating to complementary medicine ..." (ID
177 Comment)
Issues with pharmacists
Several GPs brought up the issue of pharmacists' advice
regarding medicines in breastfeeding conflicting with their
decision. Two GPs described the pharmacist as challenging
the GPs' decision:
"Diflucan [fluconazole] for nipple thrush ... But I have
been challenged by pharmacists for this before re. issue of
infant exposure, so I don't feel entirely comfortable with it."
(ID 175)
" ... It was difficult as the pharmacy rang to challenge the
Flagyl [metronidazole] use, but I double checked the RWH
breastfeeding book & it said it could be used, so we went
ahead." (ID 2)
One GP stated that "Pharmacist[s] tend to be too conser-
vative and advise against taking anything. Also, they some-
times provide advice against what I say and alarm patients
..." (ID 246 Comment)
Joint decision-making
GPs felt that certain situations warranted involvement of
several parties in the decision-making process rather than a
quick decision on their part. Although this would involve
more time and work for GPs, they thought this would help
to make a more appropriate and safe decision and increase
mothers' compliance with the recommended/prescribed
medicine.
Involving other health professionals in decision-making 
process
Seeking advice from specialists was deemed necessary in
many instances especially when treating postnatal depres-
sion.
"Had to prescribe an antidepressant. Discussed situation
with patient and her psychiatrist ... OK with decision as it
involved team care co-ordination ..." (ID 104)Jayawickrama et al. BMC Research Notes 2010, 3:82
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Involving mother in decision-making process
Many GPs discussed the situation and medicines issues at
length with the woman herself before arriving at a decision
especially with regard to postnatal depression, but in many
other instances as well.
"Postnatal depression. Antidepressant prescribed after
long discussion with patient re: prob. areas and current lit-
erature/discussion re: safety and proven side effects. I was
happy with the decision and I felt the patient was happy."
(ID 22)
"Acute mastitis. Put on Amoxil [amoxicillin] after D/W
[discussing with] Mo. [mother] re relative safety of this
antibiotic and need for antibiotic, Mo. initially concerned
but happy to take after addressing her issues." (ID 58)
The vulnerable "third party"
The fifth organising theme concerned issues of prescribing
for one person, the breastfeeding woman, thereby exposing
the vulnerable "third party" - the breastfed child - to the
effects of the medicine. The basic themes were risk, safety
and exposure to the infant.
Risk
A general statement such as "benefits outweigh risks" was
stated by 15 GPs. In some cases, the GP specifically men-
tioned considering the risk to the breastfed infant:
"Recently prescribed Cipramil [citalopram] for postnatal
depression to a woman who was breastfeeding. I felt the
risk to the baby was low & the drug was important to the
woman. I felt reassured that I have been to talks where psy-
chiatrists have said they use this drug in lactating women."
(ID 78)
One respondent added: "Be careful & know the potential
dangers." (ID 68 Comment)
In some cases, the GP was aware that the breastfeeding
woman was more concerned about the possible adverse
effect of her medicines on the breastfed infant than the GP
was: "... Patient's reluctance despite reassurance +++. No
problem for me, but patient very reluctant to take anything.
"(ID 14) and "Headache ... Paracetamol 2 tds & r/v
[review] ... patient unkeen on medication." (ID 47)
Some GPs commented that the general public are appre-
hensive about potential risks with any medicine while
breastfeeding ("Patient concern is very high ..." ID 164
Comment). One GP suggested that this perception of risk
could be negatively affecting breastfeeding rates: "... public
perception is they can't take anything. This may partly be
impacting on low uptake of breastfeeding." (ID 5 Com-
ment)
Safety
There were some medicines that GPs regarded as "safe" for
breastfeeding women; the examples given were drugs with
a longer history of use:
"Panadol [paracetamol]. To give to her. Safety. Safe and
sure." (ID 287)
"Gastritis - in patient while breastfeeding? Safety of Nex-
ium [esomeprazole] or Pariet [rabeprazole]. Decided to
use Zantac [ranitidine] - older drug more information
regarding safety." (ID 299)
Exposure to the infant
Although it could be expected that GPs consider the amount
of medicine the infant would receive through the breast
milk as an essential part of decision-making, this was rarely
alluded to. This is the only quote that refers directly to
infant exposure:
"Sleep difficulties. Advice sleep well hints. Occasional
dose of temazepam 10 mg at night and avoidance of over-
night feeding to minimize infant exposure. This medicine
has relatively short half life. Decision-making process was
difficult as lethargy and poor feeding could occur." (ID
189)
Deciding how the infant will be fed
In some scenarios it was obvious that the decision whether
the mother could or should continue breastfeeding was dis-
cussed as a separate issue from the decision about using a
medicine.
To give infant formula
GPs advised cessation of breastfeeding and the introduction
of infant formula in several instances, even in situations
that did not warrant such measures:
"A woman needed Flagyl [metronidazole] for ?anaerobic
infection. Information accessed via MIMS Annual (inter-
net). Decided to express + discard for 1 wk + 3 days + for-
mula feed, then resumed thereafter". (ID 304)
To continue breastfeeding
However, many GPs stressed the importance of continued
breastfeeding together with medicines:
"Pt. on antiepileptic. Continue BF. Checked literature
and phoned RWH. Content." (ID 192)
"Postnatal depression. Prescribed Zoloft [sertraline]
advised to continue breastfeeding. Benefit outweigh risks. I
felt Okay with decision." (ID 138)
Global theme: Complexity of managing risk in prescribing 
for breastfeeding women
From GPs' responses about their most recent experience of
making a decision concerning a medicine for a breastfeed-
ing woman, it emerged that this was a contentious area,
often involving uncertainty and requiring consultation with
various colleagues and data sources. GPs were aware that
prescribing for a breastfeeding woman leads to the inadver-
tent exposure of her infant to a potentially harmful medi-
cine, and their role was to manage this risk.
It was also evident that decision-making is a spectrum,
from a reflex action - "there was no decision-making pro-
cess (ID 76)" - to a complicated process requiring multiple
inputs and consideration. Consensus emerged among
respondents that in some conditions, such as infections likeJayawickrama et al. BMC Research Notes 2010, 3:82
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mastitis, the decision-making was straight forward and the
reports were brief and used positive sentiments, like com-
fortable, confident and  routine. In these examples, GPs
appeared to use their own knowledge and experience and
make the decision quickly and on their own. In contrast,
GPs found decisions around more complex problems, such
maternal depressive disorders, were often time-consuming
and difficult. In these examples, a number of processes
involving external sources of information may need to be
employed: phone calls to specialist doctors or pharmacists,
a range of information sources searched and long discus-
sions conducted with the woman and her family.
Discussion
This study is the first in-depth examination of Australian
GPs and their decision-making about use of medicines in
breastfeeding women. This paper is based on open-text
comments from a survey, which limits our ability to draw
conclusions. With only written responses, we were unable
to probe the respondents for further explanation for their
answers. In some studies, free-text comments may not be
representative of all participants: more articulate or less sat-
isfied respondents may bias the response [11,16]. However,
three-quarters of our respondents completed the structured
question about decision-making, providing us with 253
responses to analyse. Although analysis and reporting of
free-text comments are rarely mentioned in textbooks of
survey methods or qualitative analysis [16], qualitative
analysis can be used with free-text data that are collected in
depth [11]. Our findings provide context around how doc-
tors view the issues and have been supported by discussions
with GPs - informally and at conferences [17,18].
We found that the overarching theme for these GPs was
"complexity of managing risk in prescribing for breastfeed-
ing women". Our results confirm the findings of a study
conducted among GPs in the north of England, which
revealed that the decision-making process of prescribing
medicines was regarded as a complex issue due to various
reasons such as concerns about drug toxicity and appropri-
ateness of the treatment, and uncertainty about management
[19]. The authors found that "prescribing discomfort is a
universal, or near universal, experience of prescribers" [19]
p. 295. Concern about drug toxicity was the most common
reason for GPs' discomfort. So, it appears that prescribing is
often an uncomfortable part of any consultation, but this is
heightened when prescribing for lactating women. A Dan-
ish study found that adopting a conservative attitude and
prescribing familiar medicines was one strategy GPs
employed to save time and energy as well as reducing the
level of uncertainty [20]. A study of GPs' prescribing
behaviour in London also found a striking picture of stabil-
ity, with GPs making very few changes in their prescribing
patterns [21].
The concept of risk has become central to our everyday
thinking [22], yet a range of cognitive biases can alter our
risk perception [23]. Lyerly and colleagues found common
patterns in risk perception and reasoning affecting medical
decision-making in pregnancy [23]: a tendency to "pursue
zero risk to the fetus, independent of the absolute size of the
risk, of competing considerations, or of recognition that
fetal risk exists in other acceptable contexts" [23] p. 981.
Another tendency they identified was that the risks of inter-
vening are given precedence over the risks of failing  to
intervene; for example, maternal medicines for severe
asthma may be halted in pregnancy [23]. The same faulty
reasoning lies behind the failure to treat lactating women
with medicines when appropriate - mother and baby are
best served by appropriate medical treatment of the mother
and continued breastfeeding for the baby in the majority of
prescribing scenarios [8,24].
The public often assumes that all medicines are too risky
for breastfeeding women to take. Bellaby explains that
responsible parents will avoid an action if they believe there
is any risk to their child [25]. The community often believes
that a breastfeeding woman must be completely "pure" and
her milk absolutely free from contaminants - an impossibil-
ity in today's world [26]. In the risk-benefit analysis, the
risks of introducing infant formula are rarely considered
[27,28]. "It is the physician's obligation not to eliminate
risk, but to help patients weigh risk, benefit, and potential
harm, informed by best scientific evidence and guided by a
patient-centred ethic" [23] p. 982.
Risk communication expert, John Paling, states that "...
patients' assessment of risk is primarily determined not by
facts but by emotions" (p. 745) and suggests that doctors
remind patients that virtually all treatments are associated
with some risk [29]. His advice includes avoidance of
descriptive terms "low risk' (give numbers, eg. 1 in 10 000)
and to offer positive and negative outcomes (eg. how many
infants will not have an adverse effect) [29].
It appeared from our study that GPs' perception of risk in
prescribing is on a spectrum, from low in certain circum-
stances to high in others. GPs appeared to make straight
forward independent decisions when treating certain condi-
tions such as mastitis and other infections. These decisions
seem similar to the "rules of thumb" used by Swedish doc-
tors [30]. Our findings confirm those of a study conducted
among GPs in Victoria in the mid 1990s, which revealed a
similar picture regarding confidence in treating mastitis:
approximately three-quarters of GPs reported that they
were very confident in treating mastitis in comparison to
one quarter for treating postnatal depression [6].
However, this reflex decision-making and lack of reflec-
tion, at times led to increased risk - in this case, not for the
infant - but risk of poorer outcome for the mother. In some
cases, the GP was confident in their management, but pre-
scribed an inappropriate medicine for mastitis (e.g. penicil-Jayawickrama et al. BMC Research Notes 2010, 3:82
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lin [ID 76], amoxycillin [ID 58]). The Australian antibiotic
guidelines have recommended a penicillinase-resistant pen-
icillin for at least ten years [31,32]. Although mastitis is a
common problem in the postnatal period, it is not always
well managed by health professionals [33].
In contrast to the reflex decisions, other decisions
required multiple inputs involving much thought and time
spent on arriving at the decision. Although this more
involved process might help GPs arrive at the most appro-
priate solutions, in certain instances it did not. GPs reported
advising mothers to stop breastfeeding when taking sertra-
line, metronidazole, and other medicines, although gener-
ally these are considered safe for breastfeeding women
[34,35].
These poor decisions may indicate a lack of reliable, evi-
dence-based information on the use of medicines for breast-
feeding women. Many GPs recognised that product
information was overly cautious, that different sources of
information gave conflicting recommendations on safety of
the same drug in lactating women, and that it took time to
gather information on which to base their decisions. Com-
ments on the need for easily accessible evidence-based
information supported data from the quantitative part of the
survey where 57% of respondents indicated they would pre-
fer a reliable internet database [9].
Although some GPs reported being challenged by com-
munity pharmacists, drug information pharmacists were
highly regarded. In Toronto, Canada, the Motherisk pro-
gram provides information about medicines in pregnancy
and lactation; 89% of physicians who had called the pro-
gram commented that the service was very valuable to them
[36].
In Australia, as in other countries, drug categories have
been created to designate the safety of medicines in preg-
nancy [37,38]. Similar categories have not yet been created
for safety during lactation. The results of this survey, and
the interviews conducted with GPs in preparation for the
survey, have indicated that many GPs do not differentiate
between prescribing during pregnancy and lactation. Con-
cerns about teratogenicity when using medicines in preg-
nancy are not relevant in the postpartum period, and the
amount of medicine transferred to the infant via breast milk
is considerably less than that transferred through the pla-
centa to the fetus [8]. GPs in this study did not mention the
factors considered important when pharmacologists con-
sider risk-benefit analysis: drug transfer into milk, dose reg-
imen and infant age [8], suggesting that education in this
area could be beneficial.
Recently, the Food and Drug Administration in the US
has suggested major revisions to the physician labelling for
prescription drugs to provide better information about the
effects of medicines used during pregnancy and breastfeed-
ing [39].
There are several limitations to this study. It is likely that
GPs more interested in the topic have responded to the sur-
vey, but we had a sample of 253 GPs, with over a 50%
response rate to the survey and over 75% completing these
open comment items. If other GPs were less interested in
this issue and less confident in their management of postna-
tal issues requiring medicines, then our results may lead to
an underestimation of the actual problem. Our respondents
used a range of sources of information, which reflected
their familiarity with prescribing for breastfeeding women.
GPs not associated with the RWH would be likely to be less
familiar with the RWH Drugs and Breastfeeding book [35]
or hospital pharmacy telephone advice service. Although
other sources of evidence-based information are available
[40], it is likely that GPs who do not provide shared mater-
nity care would be less familiar with them.
Although we are not able to accurately determine the
prevalence of these postpartum conditions, the frequencies
reported indicate which conditions were commonly
encountered for treatment among the respondents, and were
similar to those found previously in Australia [5].
Analysis of written text does not allow an in-depth itera-
tive approach to deeper discovery of meanings. Some GPs'
responses were not clear cut and clarification was not possi-
ble in this study. The structured nature of the open-text
comments - and the large number - enabled an analysis that
we feel is robust, but which needs to be further explored in
qualitative research in the future.
Conclusions
The decision to prescribe medicine for a breastfeeding
woman is not always easy or simple. Doctors need to man-
age the risks by balancing the need to treat the mother for a
medical condition and concurrently support breastfeeding
of the infant. The public has great concerns about taking
medicines while breastfeeding. Guidance for making the
appropriate decision in the form of evidence based clear
guidelines and online databases are not always available or
readily accessible. Current available information may actu-
ally be contradictory, thus contributing to the complexity of
decision-making for GPs. Therefore in many instances GPs
are faced with great difficulties, even with commonly pre-
scribed medicines like metronidazole. Hence, at present
GPs believe that many decisions are "personal decisions"
rather than evidence-based and they feel a need for easily
accessible evidence based clear guidelines available in print
as well as electronically on prescribing medicines for
breastfeeding women.
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